Annual Bio-It

 
News Articles for Annual Bio-It top ^
2015/2/5
WALTHAM, Mass., Feb.
Sign-up for Proteon Therapeutics to Present at the 17th Annual BIO CEO & Investor Conference February 9th investment picks
2015/2/9
RANCHO CORDOVA, Calif., Feb.
Sign-up for Cesca Therapeutics to Present at 17th Annual BIO CEO & Investor Conference investment picks
2015/2/2
LOS ANGELES , Feb.
Sign-up for CytRx to Present at the 17th Annual BIO CEO & Investor Conference on February 9, 2015 in New York City investment picks
2015/2/6
BETHESDA, Md.
Sign-up for NW Bio To Present At 17th Annual BIO CEO & Investor Conference investment picks
2015/2/4
La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced that George F.
Sign-up for La Jolla Pharmaceutical Company to Provide Corporate Overview at 17th Annual BIO CEO & Investor Conference investment picks
2015/2/2
NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that Chief Executive Officer Pierre Legault will present a corporate overview of the Company and meet with investors at the 17 th Annual BIO CEO & Investor Conference in New York City.
Sign-up for NephroGenex to Present at the 17th Annual BIO CEO & Investor Conference investment picks
2015/2/4
http://www.marketwire.com/library/MwGo/2015/2/4/11G032299/Logo1-948842727.jpg NEWARK, CA--(Marketwired - February 04, 2015) - CymaBay Therapeutics Inc. (NASDAQ: CBAY) announced today that Harold Van Wart, Ph.D., President and Chief Executive Officer, will present a corporate update at the 17th Annual BIO CEO & Investor Conference on Monday, February 9 at 2:30 p.m. Eastern Time.
Sign-up for CymaBay to Present at 17th Annual BIO CEO & Investor Conference investment picks
2015/2/3
Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced that Maxine Gowen, Ph.D., its president and chief executive officer, will present a company overview at the 17 th Annual BIO CEO & Investor Conference on Tuesday February 10, 2015 at 8:00 a.m. EST in New York City.
Sign-up for Trevena CEO to Present at the 17th Annual BIO CEO & Investor Conference investment picks
2015/2/3
Agenus Inc. (NASDAQ: AGEN), an immunology company developing a series of immune-oncology checkpoint modulators (CPMs), heat shock protein peptide-based vaccines, and immune adjuvants, today announced that the Company will present at the 17 th Annual BIO CEO & Investor Conference on Monday, February 9 th at 4:30 p.m. Eastern Time.
Sign-up for Agenus to Present at the 17th Annual BIO CEO & Investor Conference investment picks
2015/2/4
Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Brad Smith, Chief Financial Officer, will present a corporate overview at the 17th Annual BIO CEO & Investor Conference on Monday, February 9, 2015 at 4:30 p.m. Eastern Time at the Waldorf Astoria in New York City.
Sign-up for Ocular Therapeutix™ to Present at the 17th Annual BIO CEO & Investor Conference investment picks
2015/2/3
GlycoMimetics, Inc. (NASDAQ: GLYC) announced today that Chief Executive Officer Rachel King will provide a company overview at the 17th Annual BIO CEO & Investor Conference on Monday, February 9, 2015 at 3:00 p.m. Eastern Time.
Sign-up for GlycoMimetics to Present at 17th Annual BIO CEO & Investor Conference investment picks
2015/2/2
MARLBOROUGH, Mass.
Sign-up for RXi Pharmaceuticals to Present at the 17th Annual BIO CEO & Investor Conference investment picks
2015/2/3
CLEVELAND, Feb.
Sign-up for Athersys to Present at 17th Annual BIO CEO & Investor Conference investment picks
2015/2/5
Presentation to be Webcast Live on February 10, 2015 at 1:30 PM EST PRINCETON, N.J. , Feb.
Sign-up for Soligenix to Present at the 17th Annual BIO CEO & Investor Conference in New York City investment picks
2015/2/2
NEWARK, Calif., Feb.
Sign-up for StemCells, Inc. to Participate at the 17th Annual BIO CEO & Investor Conference investment picks
2015/1/29
ST. PAUL, Minn.
Sign-up for EnteroMedics to Present at the 17th Annual BIO CEO & Investor Conference investment picks
2015/1/28
TEL-AVIV, Israel, Jan.
Sign-up for RedHill Biopharma to Present at the 17th Annual BIO CEO & Investor Conference investment picks
2015/2/6
MADISON, Wis., Feb.
Sign-up for Cellectar Biosciences to Present at the 17th Annual BIO CEO & Investor Conference 2015 investment picks
2015/2/5
BOSTON, Feb.
Sign-up for ZIOPHARM to Present at the 17th Annual BIO CEO & Investor Conference investment picks
2015/2/4
HACKENSACK, N.J. & PETACH TIKVAH, Israel , Feb.
Sign-up for BrainStorm CEO to Present at the 17th Annual BIO CEO & Investor Conference investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Annual Bio-It
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Annual Basis  |  Next: Annual Capital